Ignite Creation Date:
2025-12-24 @ 2:16 PM
Ignite Modification Date:
2026-01-18 @ 1:35 AM
Study NCT ID:
NCT04769895
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-10-17
First Post:
2021-02-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients
Sponsor:
MaaT Pharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MPOH06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None